CD4 and myeloid sarcoma: CD40 molecule plays a dual role in MS pathology: binding of CD40 by its ligand (CD40L = CD154) in mTECs can contribute to the development of central tolerance, and CD40 promotes differentiation of naive CD4+ T cells towards Th17.